Paternal Lymphocyte Immunization (PLI) is an immune-based fertility treatment that involves injecting the female partner with lymphocytes (white blood cells) from the male partner. This treatment aims to address certain types of unexplained infertility, particularly recurrent miscarriage, which may be related to immune system incompatibility between the partners. By exposing the female’s immune system to the male’s lymphocytes, PLI helps promote immunological tolerance, improving the likelihood of a successful pregnancy.
PLI is one of several treatments within reproductive immunology, a field focused on understanding how the immune system affects fertility and pregnancy. When a woman’s immune system identifies an embryo as foreign, it may mount an immune response that hinders implantation or leads to miscarriage. PLI can help “train” the immune system to accept the embryo, thus reducing the likelihood of an adverse immune response.
The procedure begins with the collection of a blood sample from the male partner. This blood is processed in a laboratory to isolate lymphocytes, which are a type of white blood cell crucial for immune response.
The lymphocytes are prepared in a sterile solution for safe injection into the female partner.
The lymphocyte solution is injected subcutaneously (under the skin) into the female partner, usually in the upper arm. The number of injections and the frequency of treatments may vary based on the patient’s needs.
After PLI, the female’s immune response is monitored through blood tests to assess tolerance levels. Additional injections may be scheduled depending on the initial response.
Each PLI session is relatively short, but it may take several sessions over a few months to achieve the desired immunological tolerance. The number of sessions needed depends on individual response.
Expected Outcomes and Success Factors in PLI Treatment
By exposing the female partner’s immune system to the male’s lymphocytes, PLI can reduce the likelihood of an immune response against the embryo, increasing the chances of a successful pregnancy.
Studies show that PLI can improve pregnancy outcomes for women who have experienced recurrent miscarriage with no other identifiable cause.
For couples undergoing ART, PLI may help reduce immune rejection and improve implantation rates, especially in cases where there has been previous implantation failure.
Success rates can vary significantly depending on each patient’s immune response and specific fertility challenges. Ongoing monitoring helps assess the effectiveness of PLI over time.
Alternative Immunological Approaches :
80% of couples achieve their dreams with IVFPULSE, enjoying successful deliveries at 40% less cost through top doctors—always with privacy and care.